49 results
Page 2 of 3
D
dlz jcnb4
28 Oct 21
$4.31M in equity, sold $4.31M, 54 investors
11:29am
8-K
EX-2.1
7ypteew 98a6l1
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
6c6qv ckjn9f5zy
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
0qdmy3pb9ulhtyddw2
24 Sep 21
Annual report
7:31am
424B3
puetvdon9bof6doq
22 Jul 21
Prospectus supplement
10:27am
D
n2ox5o5n63tmgz gwgo
19 Jul 21
$12M in equity / options, sold $12M, 1 investor
6:13am
8-K
EX-10.1
icjy3dlpzfyh
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
424B3
fma64cjbz2q6
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-10.2
52xn akx6gbpcm9b64
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
10-Q
fx0e4a7dbhel9kuqc0
17 Dec 20
Quarterly report
12:00am
424B4
fhz2e6
13 Nov 20
Prospectus supplement with pricing info
8:52pm
8-K
EX-1.1
q4uequno8a2pbk53
12 Nov 20
InMed Announces Pricing of US$8M Public Offering and
10:15am